BPC-157 is not currently approved by the FDA for the treatment of specific medical conditions
Aby osign optymalne rezultaty ze stosowania BPC157, zaleca si stosowanie go codziennie przez okres do 3 miesicy, po czym nastpuje jeden do dwch miesicy przerwy
A small amount, approximately 1.2% of the orally administered dose, is absorbed passively without IF
Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia)
Darker skin tends to produce thicker lesions and may respond better to treatments specifically made for those symptoms
Research has found B12 effective in treating pain from diabetic neuropathy and other conditions